Navigation Links
NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14
Date:11/9/2007

PHOENIX, Nov. 9 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a health science company and a world leader in stabilized rice bran (SRB), announced today that it will release its third quarter financial results on Wednesday, November 14 after the market closes.

Management will host the conference call on November 14 at 5:30 PM EST to review NutraCea's 2007 third quarter financial results and provide management updates. Parties interested in listening to the conference call should call 800-240-8926. International callers should dial 303-262-2143. The call is also available via a webcast that can be accessed at http://www.vcall.com/IC/CEPage.asp?ID=123078 and will be archived for 30 days.

About NutraCea

NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through its wholly-owned subsidiary, RiceX, the Company manufactures (as well as distributes) products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual properties to create a range of proprietary product formulations, delivery systems and whole-food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice- processing. In addition to its whole-foods products, NutraCea develops families of health- promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the Company's filings with the SEC, and you can visit the NutraCea Web site http://www.NutraCea.com.

Company Contact:

Margie Adelman

Senior V.P. NutraCea

602-522-3000

916-220-3500 cell

madelman@nutracea.com

Investor
'/>"/>

SOURCE NutraCea
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. NutraCea Appoints Financial Relations Board as New Investor Relations Firm
2. More than two-thirds of sexually active NYC youth use condoms, but other forms of birth control lag
3. Haemacure Reports Third Quarter 2007 Results
4. Burgeoning Population of Hepatitis C Virus Patients in Need of Second- and Third-Line Treatment Options
5. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
6. Martek Announces Third Quarter 2007 Financial Results
7. MDS Reports Third Quarter 2007 Results
8. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
9. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
10. Webcast Alert: Heska Announces Third Quarter 2007 Earnings Conference Call Webcast
11. AABB and Fenwal Sponsor Third Annual Blood Collectors Week

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...pper sequestering drug tetrathiomolybdate (TM) has...tment of Wilson disease, a disease caused by an ov...That much is known. Very little, however, is known..., A new study led by Northwestern University res...three-dimensional structure of TM bound to copper-...
(Date:11/26/2009)... Dr. David Kim of the Live Life A...ery in Dallas , is one of a growing number of phys... networking sites to connect with individuals who ...o fight morbid obesity. Dr. Kim is utilizing Faceb...on about his practice with the community. , ...
(Date:11/25/2009)...EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmos...utachiropractorcanalsogivepatientsthehelptheyneed....reyourjaw(mandible)contacts/connectswithyourskull(...edwithTMJdysfunctionarepainwithchewing,clickingorp...TMJdysfunctionincluding:headaches,fatigue,sleepdis...
(Date:11/25/2009)...TORONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,a...alizationsoftwarelaunchesasuiteofnewleadingedgecli...areplatformatthisyear,sRadiologicalSocietyofNorthA...09(Booth5800,HallA).Theapplicationsleveragetheuniq...zedMRIimagingcoilsandsupportmultipleimagingmodalit...
(Date:11/25/2009)...SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQual...ter Spare the Air Alert forThursday,...relogsoranyothersolidfuel,bothindoorsandoutdoors. ...irqualitytomorrow,"saidJackBroadbent,executiveoffi...respectthehealthoftheirneighborsandfellowcommunity...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...Journal study finds natural, less expensive treatm...fferers , , PRINCETON, N.J., Dec. 2 With its... season is, for most, anticipated with excitement....rassing and debilitating gastrointestinal attacks,...
... PA. Patients treated with radiation prior to su...ces of cancer recurrence and better overall surviv..., The report examined a treatment called neoadjuv...chemotherapy and/or radiation. , Neoadjuvant the...
... Findings published in the December 1, 2008, issue...merican Association for Cancer Research, show lapa...cer, while women with HER2-negative breast cancer ...percent prevents some people from receiving optima...
... Dec. 2 /PRNewswire-FirstCall/ - NUCRYST Pharmaceu...cal products that fight infection and inflammation...received from its majority shareholder, The Westai...reholders. This equates to a return of capital of ...
... 2 Today Pascal Metrics Inc.,publicly announces i...agement,services for hospitals and healthcare syst...pidly has become a worldwide leader for clients se...safer from,medical failure and errors. , Acc...
...Barotz Dental is now one of only two dental,practi...ew Attachment,Procedure). This is the only laser ...proved for new attachment of gum and bone tissue a...nd discomfort to the,patient, closes the periodont...
Other Medicine News:Health News:Holiday Season Brings New Hope to Millions Who Suffer from Common Chronic Health Disorder 2Health News:HER2 levels may aid in treatment selection for metastatic breast cancer 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 3Health News:Pascal Metrics Announces Patient Safety Culture Services Offering 2Health News:Barotz Dental Now Offering Laser Gum Therapy 2
(Date:11/25/2009)...,, PRINCETON,N.J.,Nov.25/PRNewswire-FirstCal...harmaceuticalcompanycommittedtodiscovering,develop...ons,reportedfinancialresultsforthefiscalyearendedS...8.4millionincash,cashequivalentsandshortterminvest..., RG7128 ,, Phase2bTrial ,, InlateNov...
(Date:11/25/2009)...,, WESTPALMBEACH,Fla.,Nov.25/PRNewswire-Firs...cans,especiallythe27millionlivingwithuntreated hea...ologistCindyBeyer. ,, Dr.Beyer,seniorvicepresid...ingcareand hearingaids companies,saidstudieshaveli...tion,"whichcaneasilybeintensifiedatholidaygatherin...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker....einitscatalogue: ,, UnitedStatesDentalDevicesM....reportlinker.com/p0158733/United-States-Dental-De...,, UnitedStatesDentalDevicesMarketAnalysisandFo...essentialsourceforin-depthinformationanddatarelati...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12UCLA cancer researchers develop model that may help identify cancer stem cells 8850 1UCLA cancer researchers develop model that may help identify cancer stem cells 8850 2UCLA cancer researchers develop model that may help identify cancer stem cells 8850 3Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 1Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 2Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 3Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 4CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 1CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 2CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 3CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 4CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 5
...sented at the 2008 iSBTc Annual Meeting -, - Conf... discuss,results -, BRANFORD, Conn., Nov. 3 Cura...reliminary data from an ongoing Phase II,trial of ...ets GPNMB, for,the treatment of patients with unre...ck Hwu, Co-Principal Investigator, and Professor a...
...cent of patients achieve undetectable viral load i...ment with standard of care, SAN FRANCISCO, Nov. 1...435, an investigational protease inhibitor (PI) be... chronic hepatitis C virus,(HCV) infection. Tibote...including a late-breaker poster on the proof-of-pr...
Other Medicine Technology:CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 4CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 5CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 6CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 7Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 2Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 3Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 4Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 5
...ormat) microfiltration units provide a reproducibl...lution onto nitrocellulose or Zeta-Probe membrane....y using interchangeable templates to form the 96-w...ot SF apparatus. Each is available as a complete, ...
...ormat) microfiltration units provide a reproducibl...lution onto nitrocellulose or Zeta-Probe membrane....y using interchangeable templates to form the 96-w...ot SF apparatus. Each is available as a complete, ...
Dot Blotting Apparatus
...orous vacuum plate, reservoir seal O-ring, sealing.... The Model 785 vacuum blotter quickly and effici...o a nylon membrane. Because it generally requires ... can be separated on a gel, transferred to a membr...
Medicine Products: